Market Overview:
The global statin market size reached US$
14.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$
17.5 Billion by 2027, exhibiting a growth rate (CAGR) of
3.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Statin is a lipid-lowering medication, an agent that is consumed by patients to reduce their blood cholesterol levels. Atorvastatin, rosuvastatin, lovastatin and simvastatin are the most common types of statins available in the market. They aid in preventing the instances of atherosclerosis and heart attacks and have significant anti-inflammatory and plaque-stabilizing effects. These drugs also aid in minimizing vascular inflammation and oxidative stress in the body. Besides this, statin interferes with the production of enzymes that are crucial for the liver to produce cholesterol, thus aiding in lowering the overall blood cholesterol levels in the body.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
The increasing prevalence of hypercholesterolemia across the globe is among the key factors driving the growth of the market. This disorder is highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, obesity and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, increasing consumer preference for over-the-counter (OTC) drugs is another factor contributing to the market growth. In comparison to brand name drugs, OTC variants are usually more affordable. Additionally, the growing adoption of combination therapies that use statin with other cholesterol diminishing compounds, such as ezetimibe, is acting as another growth-inducing factor. Research has found statin-ezetimibe combination therapy to be capable of achieving near-normal lipid profiles in familial hypercholesterolemia patients and significantly reducing the risk of CVDs occurrence. Other factors, including improving healthcare infrastructure and growing health consciousness among consumers, are projected to drive the market further.
IMARC Group’s latest report provides a deep insight into the global statin market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the statin industry in any manner.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global statin market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, therapeutic area, drug class, application and distribution.
Breakup by Type:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Synthetic Statins
- Natural Statins
Breakup by Therapeutic Area:
- Cardiovascular Disorders
- Obesity
- Inflammatory Disorders
- Others
Breakup by Drug Class:
- Atorvastatin
- Fluvastatin
- Lovastatin
- Pravastatin
- Simvastatin
- Others
Breakup by Application:
Breakup by Distribution:
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, AstraZeneca, Aurobindo Pharma, Biocon, GlaxoSmithKline, Merck & Co., Novartis, Pfizer, etc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Type, Therapeutic Area, Drug Class, Application, Distribution, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, AstraZeneca, Aurobindo Pharma, Biocon, GlaxoSmithKline, Merck & Co., Novartis and Pfizer |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global statin market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global statin market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the therapeutic area?
- What is the breakup of the market based on the drug class?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the distribution?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the market?
- What is the structure of the global statin market and who are the key players?
- What is the degree of competition in the market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Statin Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Synthetic Statins
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Natural Statins
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Therapeutic Area
7.1 Cardiovascular Disorders
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Obesity
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Inflammatory Disorders
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Drug Class
8.1 Atorvastatin
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Fluvastatin
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Lovastatin
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Pravastatin
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Simvastatin
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Application
9.1 Dyslipidemia
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Others
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Distribution
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Europe
11.2.1 Germany
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 France
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 United Kingdom
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 Italy
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Spain
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Russia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Asia Pacific
11.3.1 China
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 Japan
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 India
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 South Korea
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Australia
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Indonesia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 AstraZeneca
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Aurobindo Pharma
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Biocon
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 GlaxoSmithKline
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Merck & Co.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Novartis
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Pfizer
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
List of Figures
Figure 1: Global: Statin Market: Major Drivers and Challenges
Figure 2: Global: Statin Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Statin Market: Breakup by Type (in %), 2021
Figure 4: Global: Statin Market: Breakup by Therapeutic Area (in %), 2021
Figure 5: Global: Statin Market: Breakup by Drug Class (in %), 2021
Figure 6: Global: Statin Market: Breakup by Application (in %), 2021
Figure 7: Global: Statin Market: Breakup by Distribution (in %), 2021
Figure 8: Global: Statin Market: Breakup by Region (in %), 2021
Figure 9: Global: Statin Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 10: Global: Statin (Synthetic Statins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Statin (Synthetic Statins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Statin (Natural Statins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Statin (Natural Statins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Statin (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Statin (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Statin (Obesity) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Statin (Obesity) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Statin (Inflammatory disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Statin (Inflammatory disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Statin (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Statin (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Statin (Atorvastatin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Statin (Atorvastatin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Statin (Fluvastatin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Statin (Fluvastatin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Statin (Lovastatin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Statin (Lovastatin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Statin (Pravastatin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Statin (Pravastatin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Statin (Simvastatin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Statin (Simvastatin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Statin (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Statin (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Statin (Dyslipidemia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Statin (Dyslipidemia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Statin (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Statin (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Statin (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Statin (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Statin (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Statin (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: Statin (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: Statin (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: North America: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: North America: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: United States: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: United States: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Canada: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Canada: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Asia Pacific: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Asia Pacific: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: China: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: China: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Japan: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Japan: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: India: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: India: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: South Korea: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: South Korea: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Australia: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Australia: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Indonesia: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Indonesia: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Europe: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Europe: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Germany: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Germany: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: France: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: France: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: United Kingdom: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: United Kingdom: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Italy: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Italy: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Spain: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Spain: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Russia: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Russia: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Others: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Others: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Latin America: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Latin America: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Brazil: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Brazil: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Mexico: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Mexico: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Others: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: Others: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Middle East and Africa: Statin Market: Sales Value (in Million US$), 2016 & 2021
Figure 91: Middle East and Africa: Statin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Global: Statin Industry: SWOT Analysis
Figure 93: Global: Statin Industry: Value Chain Analysis
Figure 94: Global: Statin Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Statin Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Statin Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Statin Market Forecast: Breakup by Therapeutic Area (in Million US$), 2022-2027
Table 4: Global: Statin Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 5: Global: Statin Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Statin Market Forecast: Breakup by Distribution (in Million US$), 2022-2027
Table 7: Global: Statin Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 8: Global: Statin Market: Competitive Structure
Table 9: Global: Statin Market: Key Players